Globes |
Teva finds positive results in advanced trials for asthma drug
Reuters Reslizumab, an investigational antibody, showed statistically significant reductions in the frequency of asthma exacerbations – episodes of progressively worsening shortness of breath, coughing, wheezing, and chest tightness – compared to patients … Teva's Reslizumab Shows Reduction In Asthma Exacerbations In Clinical Studies Teva reports positive Phase III asthma drug results |
View full post on asthma – Google News